Net Loss Per Share (Tables)

9 Months Ended

Sep. 30, 2026

Schedule of basic and diluted net loss per share

Basic and diluted net loss per share attributable to common shareholders of Biohaven was calculated as follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2026		2025		2026		2025
Numerator:

Net loss	$	(129,279)	$	(173,443)	$	(397,122)	$	(593,267)
Denominator:
Weighted average common shares outstanding—basic and diluted	151,040,349		105,815,038		149,776,602		103,391,267
Net loss per share — basic and diluted	$	(0.86)	$	(1.64)	$	(2.65)	$	(5.74)

Schedule of potentially anti-dilutive securities excluded from calculation of diluted net loss per share

The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common shareholders for the periods indicated because including them would have had an anti-dilutive effect:


	As of September 30,
	2026	2025
Options to purchase common shares	20,264,906	15,799,622
Warrants to purchase common shares	—	294,195
Restricted share units	888,236	1,414,446
Total	21,153,142	17,508,263